LIFECORE BIOMEDICAL, INC. Research and Development Arrangement, Contract to Perform for Others, Compensation Earned
LIFECORE BIOMEDICAL, INC. (LFCR) reported Research and Development Arrangement, Contract to Perform for Others, Compensation Earned of $103.00 thousand for the 3-month period ending 2012-11-25, per its 10-Q filed 2013-01-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned · last filed 2013-01-04
- LIFECORE BIOMEDICAL, INC. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2012-11-25 was $103.00K.
| Period end | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 3 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 6 month |
|---|---|---|
| 2012-11-25 | $103.00K 10-Q · filed 2013-01-04 | $138.00K 10-Q · filed 2013-01-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |